3400 Enterprise Drive
Wilmington, NC 28405
United States
QCL is a CDMO privately owned and operated since 1998. QCL excels in pre-formulation, formulation development, and delivering early phase clinical trial materials on aggressive timelines. We provide analytical development and validation, stability studies, and testing of small and large molecule APIs, finished products, and raw materials. New construction doubles our footprint to 200,000 ft2 in Q2 2023 expanding services into late phase clinical and commercial GMP manufacturing including state of the art sterile fill-finish for both small and large molecules.